uPARAP/Endo180 Regulation by TGF-β1 in Murine Lung Fibroblasts.

被引：0
|
作者：
Bundesmann, M. M. [1 ]
Wagner, T. E. [1 ]
Schnapp, L. M. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3469
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180
    Engelholm, Lars H.
    Melander, Maria C.
    Hald, Andreas
    Persson, Morten
    Madsen, Daniel H.
    Jurgensen, Henrik J.
    Johansson, Kristina
    Nielsen, Christoffer
    Norregaard, Kirstine S.
    Ingvarsen, Signe Z.
    Kjaer, Andreas
    Trovik, Clement S.
    Laerum, Ole D.
    Bugge, Thomas H.
    Eide, Johan
    Behrendt, Niels
    JOURNAL OF PATHOLOGY, 2016, 238 (01): : 120 - 133
  • [22] Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy
    Curino, A
    Engelholm, L
    Yamada, S
    Holmbeck, K
    Lund, L
    Molinolo, A
    Behrendt, N
    Nielsen, BS
    Bugge, TH
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) : A4 - A4
  • [23] uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
    Tania Durré
    Florent Morfoisse
    Charlotte Erpicum
    Marie Ebroin
    Silvia Blacher
    Melissa García-Caballero
    Christophe Deroanne
    Thomas Louis
    Cédric Balsat
    Maureen Van de Velde
    Seppo Kaijalainen
    Frédéric Kridelka
    Lars Engelholm
    Ingrid Struman
    Kari Alitalo
    Niels Behrendt
    Jenny Paupert
    Agnès Noel
    Nature Communications, 9
  • [24] uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
    Durre, Tania
    Morfoisse, Florent
    Erpicum, Charlotte
    Ebroin, Marie
    Blacher, Silvia
    Garcia-Caballero, Melissa
    Deroanne, Christophe
    Louis, Thomas
    Balsat, Cedric
    Van de Velde, Maureen
    Kaijalainen, Seppo
    Kridelka, Frederic
    Engelholm, Lars
    Struman, Ingrid
    Alitalo, Kari
    Behrendt, Niels
    Paupert, Jenny
    Noel, Agnes
    NATURE COMMUNICATIONS, 2018, 9
  • [25] The effect of a novel TGF-β inhibitor on TGF-β/Smad signaling in normal dermal fibroblasts.
    Mori, Y
    Ishida, W
    Bhattacharyya, S
    Varga, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S479 - S479
  • [26] TGF-β1 and IFN-γ regulate myofibroblastic phenotype of palatal fibroblasts.
    Yokozeki, M
    Moriyama, K
    Baba, Y
    Shimokawa, H
    Kuroda, T
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 929 - 929
  • [27] TGF-β1 and IFN-γ regulate myofibroblastic phenotype of palatal fibroblasts.
    Yokozeki, M
    Moriyama, K
    Baba, Y
    Shimokawa, H
    Kuroda, T
    JOURNAL OF DENTAL RESEARCH, 1998, 77 (05) : 1302 - 1302
  • [28] Endogenous SMADs mediate TGF-β transcriptional responses in fibroblasts.
    Chen, S
    Yuan, WH
    Lo, S
    Trojanowska, M
    Varga, J
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S199 - S199
  • [29] The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers
    Nielsen, Christoffer Fagernaes
    van Putten, Sander Maarten
    Lund, Ida Katrine
    Melander, Maria Carlsen
    Norregaard, Kirstine Sandal
    Jurgensen, Henrik Jessen
    Reckzeh, Kristian
    Christensen, Kristine Rothaus
    Ingvarsen, Signe Ziir
    Gardsvoll, Henrik
    Jensen, Kamilla Ellermann
    Hamerlik, Petra
    Engelholm, Lars Henning
    Behrendt, Niels
    ONCOTARGET, 2017, 8 (27) : 44605 - 44624
  • [30] Requirement for the collagen receptor Endo180 in collagen gel contraction mediated by corneal fibroblasts
    Nishida, Koichi
    Sugioka, Koji
    Murakami, Junko
    Kodama-Takahashi, Aya
    Nanri, Isamu
    Mishima, Hiroshi
    Nishida, Teruo
    Kusaka, Shunji
    EXPERIMENTAL EYE RESEARCH, 2020, 191
12345